Tamoxifen: an enduring star

J Natl Cancer Inst. 2007 Feb 21;99(4):258-60. doi: 10.1093/jnci/djk072.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / prevention & control*
  • Cost-Benefit Analysis
  • Estrogen Receptor Modulators / adverse effects
  • Estrogen Receptor Modulators / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Multicenter Studies as Topic
  • Odds Ratio
  • Randomized Controlled Trials as Topic
  • Receptors, Estrogen / analysis*
  • Risk Assessment
  • Risk Factors
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use*
  • Time Factors
  • Venous Thrombosis / chemically induced

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor Modulators
  • Receptors, Estrogen
  • Tamoxifen